TCMBANKGE000181 |
PIM1 |
PIM |
Pim-1 proto-oncogene, serine/threonine kinase |
TCMBANKGE000201 |
ESR1 |
ER; ESR; ESRA; ESTRR; Era; NR3A1 |
estrogen receptor 1 |
TCMBANKGE000252 |
PDE4A |
DPDE2; PDE4; PDE46 |
phosphodiesterase 4A |
TCMBANKGE000309 |
SCN5A |
CDCD2; CMD1E; CMPD2; HB1; HB2; HBBD; HH1; ICCD; IVF; LQT3; Nav1.5; PFHB1; SSS1; VF1 |
sodium voltage-gated channel alpha subunit 5 |
TCMBANKGE000425 |
DRD1 |
DADR; DRD1A |
dopamine receptor D1 |
TCMBANKGE000478 |
CHEK1 |
CHK1 |
checkpoint kinase 1 |
TCMBANKGE000633 |
ADRB2 |
ADRB2R; ADRBR; B2AR; BAR; BETA2AR |
adrenoceptor beta 2 |
TCMBANKGE000766 |
ACHE |
ACEE; ARACHE; N-ACHE; YT |
acetylcholinesterase (Cartwright blood group) |
TCMBANKGE000813 |
DPP4 |
ADABP; ADCP2; CD26; DPPIV; TP103 |
dipeptidyl peptidase 4 |
TCMBANKGE000869 |
DRD2 |
D2DR; D2R |
dopamine receptor D2 |
TCMBANKGE000965 |
CHRNA7 |
CHRNA7-2; NACHRA7 |
cholinergic receptor nicotinic alpha 7 subunit |
TCMBANKGE001073 |
PTGS2 |
COX-2; COX2; GRIPGHS; PGG/HS; PGHS-2; PHS-2; hCox-2 |
prostaglandin-endoperoxide synthase 2 |
TCMBANKGE001194 |
ADRA2A |
ADRA2; ADRA2R; ADRAR; ALPHA2AAR; ZNF32 |
adrenoceptor alpha 2A |
TCMBANKGE001506 |
ADRA1B |
ADRA1; ALPHA1BAR |
adrenoceptor alpha 1B |
TCMBANKGE001816 |
HRH1 |
H1-R; H1R; HH1R; hisH1 |
histamine receptor H1 |
TCMBANKGE001943 |
ADRA1D |
ADRA1; ADRA1A; ADRA1R; ALPHA1; DAR; dJ779E11.2 |
adrenoceptor alpha 1D |
TCMBANKGE003157 |
CHRM2 |
HM2 |
cholinergic receptor muscarinic 2 |
TCMBANKGE003625 |
SLC6A4 |
5-HTT; 5-HTTLPR; 5HTT; HTT; OCD1; SERT; SERT1; hSERT |
solute carrier family 6 member 4 |
TCMBANKGE004266 |
AR |
AIS; AR8; DHTR; HUMARA; HYSP1; KD; NR3C4; SBMA; SMAX1; TFM |
androgen receptor |
TCMBANKGE005535 |
CHRM1 |
HM1; M1; M1R |
cholinergic receptor muscarinic 1 |
TCMBANKGE006943 |
CHRM3 |
EGBRS; HM3; PBS |
cholinergic receptor muscarinic 3 |
TCMBANKGE008056 |
ADRA2C |
ADRA2L2; ADRA2RL2; ADRARL2; ALPHA2CAR |
adrenoceptor alpha 2C |
TCMBANKGE008124 |
ADRA2B |
ADRA2L1; ADRA2RL1; ADRARL1; ALPHA2BAR; FAME2; alpha-2BAR |
adrenoceptor alpha 2B |
TCMBANKGE008700 |
CHRNA2 |
- |
cholinergic receptor nicotinic alpha 2 subunit |
TCMBANKGE008702 |
OPRM1 |
LMOR; M-OR-1; MOP; MOR; MOR1; OPRM |
opioid receptor mu 1 |
TCMBANKGE009256 |
SLC6A2 |
NAT1; NET; NET1; SLC6A5 |
solute carrier family 6 member 2 |
TCMBANKGE009294 |
HTR3A |
5-HT-3; 5-HT3A; 5-HT3R; 5HT3R; HTR3 |
5-hydroxytryptamine receptor 3A |
TCMBANKGE009455 |
CHRM5 |
HM5 |
cholinergic receptor muscarinic 5 |
TCMBANKGE009758 |
PDE3A |
CGI-PDE; CGI-PDE A; CGI-PDE-A; HTNB |
phosphodiesterase 3A |
TCMBANKGE011923 |
CHRM4 |
HM4; M4R |
cholinergic receptor muscarinic 4 |
TCMBANKGE012155 |
SLC6A3 |
DAT; DAT1; PKDYS; PKDYS1 |
solute carrier family 6 member 3 |
TCMBANKGE013226 |
DRD4 |
D4DR |
dopamine receptor D4 |
TCMBANKGE013826 |
DRD5 |
DBDR; DRD1B; DRD1L2 |
dopamine receptor D5 |
TCMBANKGE014050 |
GABRA1 |
ECA4; EIEE19; EJM; EJM5 |
gamma-aminobutyric acid type A receptor subunit alpha1 |
TCMBANKGE014625 |
OPRD1 |
DOP; DOR; DOR1; OPRD |
opioid receptor delta 1 |
TCMBANKGE014790 |
ADRB1 |
ADRB1R; B1AR; BETA1AR; FNSS2; RHR |
adrenoceptor beta 1 |